Charles Darwin University

CDU eSpace
Institutional Repository

 
CDU Staff and Student only
 

Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci

Howden, Benjamin P., Holt, Kathryn E., Lam, Margaret M. C., Seemann, Torsten, Ballard, Susan, Coombs, Geoffrey W., Tong, Steven Y. C., Grayson, M. Lindsay, Johnson, Paul D. R. and Stinear, Timothy P. (2013). Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci. mBio,4(4):e00412-13-1-e00412-13-9.

Document type: Journal Article
Attached Files (Some files may be inaccessible until you login with your CDU eSpace credentials)
Name Description MIMEType Size Downloads
Download this reading Tong_40629.pdf Published version application/pdf 2.46MB 56
Reading the attached file works best in Firefox, Chrome and IE 9 or later.

IRMA ID bsmithxPUB196
NHMRC Grant No. 1027874
1023526
Title Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci
Author Howden, Benjamin P.
Holt, Kathryn E.
Lam, Margaret M. C.
Seemann, Torsten
Ballard, Susan
Coombs, Geoffrey W.
Tong, Steven Y. C.
Grayson, M. Lindsay
Johnson, Paul D. R.
Stinear, Timothy P.
Journal Name mBio
Publication Date 2013
Volume Number 4
Issue Number 4
ISSN 2150-7511   (check CDU catalogue  open catalogue search in new window)
Scopus ID 2-s2.0-84883343175
Start Page e00412-13-1
End Page e00412-13-9
Total Pages 9
Place of Publication United States
Publisher American Society for Microbiology Press (ASM Press)
HERDC Category C1 - Journal Article (DIISR)
Abstract Nosocomial outbreaks of vancomycin-resistant Enterococcus faecium (VREfm) are thought to occur by transmission of VREfm between patients, predicting that infection control interventions will limit cross-transmission. Despite implementation of such strategies, the incidence of VREfm infections continues to rise. We aimed to use genomics to better understand the epidemiology of E. faecium within a large hospital and investigate the reasons for failure of infection control strategies. Whole-genome sequencing was performed on 61 E. faecium (36 VREfm) isolates, predominately from blood cultures collected at a single hospital between 1998 and 2009, and on five vanB-positive anaerobic commensal bacteria isolated from human feces. Phylogenomic analysis and precise mapping of the vanB gene, which contains the Tn1549 transposon, showed that at least 18 of the 36 VREfm isolates had acquired the transposon via independent insertion events, indicating de novo generation of VREfm rather than cross-transmission. Furthermore, Tn1549 sequences found in 15 of the 36 VREfm isolates were the same as the Tn1549 sequence from one of the gut anaerobes. National and international comparator E. faecium isolates were phylogenetically interspersed with isolates from our hospital, suggesting that our findings might be globally representative. These data demonstrate that VREfm generation within a patient is common, presumably occurring in the human bowel during antibiotic therapy, and help explain our inability to reduce VREfm infections. A recommendation from our findings is that infection control practices should include screening patients for specific hospital clones of vancomycin-susceptible E. faecium rather than just VREfm.

IMPORTANCE
Enterococcus faecium is an increasingly important human pathogen causing predominantly antibiotic-resistant infections in hospitalized patients. Large amounts of health care funding are spent trying to control antibiotic-resistant bacteria in hospitals globally, yet in many institutions around the world, vancomycin-resistant E. faecium (VREfm) infections continue to rise. The new findings from this study help explain the failures of our current approaches to controlling vanB VREfm in health care institutions. Given the importance of this bacterium as a cause of hospital-acquired infections and the difficulties faced by infection control units in trying to prevent colonization in their institutions, the novel findings from this study provide evidence that a new approach to controlling VREfm in hospitals is required. In particular, more attention should be given to understanding the epidemiology of hospital-adapted vancomycin-susceptible E. faecium, and patients at higher risk for de novo generation of VREfm need to be identified and optimally managed.

DOI http://dx.doi.org/10.1128/mBio.00412-13   (check subscription with CDU E-Gateway service for CDU Staff and Students  check subscription with CDU E-Gateway in new window)
Additional Notes This is an Open Access article distributed under the terms of the Creative Commons Attribution License 3.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Description for Link Link to CC Attribution 3.0 License
URL https://creativecommons.org/licenses/by/3.0/au/legalcode


© copyright

Every reasonable effort has been made to ensure that permission has been obtained for items included in CDU eSpace. If you believe that your rights have been infringed by this repository, please contact digitisation@cdu.edu.au.

 
Versions
Version Filter Type
Access Statistics: 36 Abstract Views, 56 File Downloads  -  Detailed Statistics
Created: Thu, 07 Aug 2014, 17:17:47 CST